Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle.
about
Oncolytic Sendai virus-based virotherapy for cancer: recent advancesAndrogen-regulated transcriptional control of sialyltransferases in prostate cancer cellsInactivated Sendai virus strain Tianjin induces apoptosis in breast cancer MCF-7 cells by promoting caspase activation and Fas/FasL expression.Mechanisms of Oncolysis by Paramyxovirus SendaiOncolysis by paramyxoviruses: preclinical and clinical studies.Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.Effective photodynamic therapy in drug-resistant prostate cancer cells utilizing a non-viral antitumor vector (a secondary publication)An RNA Molecule Derived From Sendai Virus DI Particles Induces Antitumor Immunity and Cancer Cell-selective Apoptosis.Inactivated Sendai virus strain Tianjin, a novel genotype of Sendai virus, inhibits growth of murine colon carcinoma through inducing immune responses and apoptosis.Oncolytic virus therapy for prostate cancer.Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapyUpdate on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool.Current status of clinical trials assessing oncolytic virus therapy for urological cancers.A biomimetic approach to hormone resistant prostate cancer cell isolation using inactivated Sendai virus (HVJ-E).13-Cis retinoic acid can enhance the antitumor activity of non-replicating Sendai virus particle against neuroblastoma.RIG-I: a multifunctional protein beyond a pattern recognition receptor.Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells.Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients.Inactivated Sendai Virus (HVJ-E) Immobilized Electrospun Nanofiber for Cancer Therapy.Combination of automated solid-phase and enzymatic oligosaccharide synthesis provides access to α(2,3)-sialylated glycans.Virosome presents multimodel cancer therapy without viral replication.Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells.IPS-1 plays a dual function to directly induce apoptosis in murine melanoma cells by inactivated Sendai virus.Genetically engineered Newcastle disease virus for prostate cancer: a magic bullet or a misfit.Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma.Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope.Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study).Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment.
P2860
Q26825239-7057D00B-1997-44CE-BA0C-F8201AC2B5B8Q34162748-BCC8A584-4A55-4AFD-95EA-0172ED5F92EBQ35068459-06EB7472-D0D5-4B26-B242-61A3D6339AA5Q35721486-D1B8C5F8-7E46-4969-AA25-37E3AC5BE074Q35861933-F87C8334-8166-4AA9-BF59-6747875B6202Q35861936-51CE8E0C-CD43-4B29-8944-9855488D35F8Q36007528-139DC1DF-3B68-42BB-A8ED-38836AEEC747Q36582852-AF0A3304-4C51-402A-A005-DD2221092676Q37352017-56F019D7-6FFC-470A-9A44-39CF854C8643Q37615535-363A39C6-8C11-44FA-8FE7-6682BA1880CDQ37708026-950E4826-A63A-421E-84DA-5158A2F87E47Q37780547-F73640BB-AA0F-4CB3-A267-B44F2911A025Q38741837-E277CACF-3FC6-4B16-9DA0-63625A54872AQ38820595-81769924-0E15-4316-AA6D-78262B531F78Q39248316-3D6F2C8A-E964-4B88-8EB8-5545DD18EE69Q39358994-7621BAD2-6042-4C36-B631-26E4946B32E0Q39619019-756D049F-CD9B-4C2C-92E4-5976D6D92987Q40204247-FAFB4ED1-B76F-48BA-8F63-D1951CDFEFD1Q41023203-8B24AF51-FDFE-4407-9CE2-E4A22A78D8F9Q41261153-908EDE61-0A8C-4B2C-958D-59E1F8BD8D5AQ41812409-A19CE98E-595E-4042-9E96-FCFA05F8068AQ41930795-4FE1B7DC-BC85-4DCD-A038-76281D71F352Q44068008-1EF52776-7562-4C82-BB70-B73D536ADC95Q44319257-58DD208D-65E8-4A17-A2CF-01A8FF9BA469Q45863017-A3445B75-FD86-4DFB-B25D-6677D1DDCBDDQ45887671-2573EE86-84D6-4158-8940-BD1367044D3EQ55366271-DAE17696-9696-48B8-BC66-9C40D1F6600FQ55508841-304993DB-105A-4C3A-848B-16E775FA1C0F
P2860
Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Efficient eradication of hormo ...... tivated Sendai virus particle.
@en
Efficient eradication of hormo ...... tivated Sendai virus particle.
@nl
type
label
Efficient eradication of hormo ...... tivated Sendai virus particle.
@en
Efficient eradication of hormo ...... tivated Sendai virus particle.
@nl
prefLabel
Efficient eradication of hormo ...... tivated Sendai virus particle.
@en
Efficient eradication of hormo ...... tivated Sendai virus particle.
@nl
P2093
P356
P1476
Efficient eradication of hormo ...... tivated Sendai virus particle.
@en
P2093
Takehiro Inoue
Yasufumi Kaneda
Yasuhide Miyamoto
Yoshifumi Kawaguchi
P304
P356
10.1002/IJC.24234
P577
2009-05-01T00:00:00Z